- Home
- HROW vs GAB Comparison
HROW vs GAB Comparison
Compare HROW & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- GAB
- Stock Information
- Founded
- HROW 1998
- GAB 1986
- Country
- HROW United States
- GAB United States
- Employees
- HROW N/A
- GAB N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- GAB Investment Managers
- Sector
- HROW Health Care
- GAB Finance
- Exchange
- HROW Nasdaq
- GAB Nasdaq
- Market Cap
- HROW 1.9B
- GAB 1.6B
- IPO Year
- HROW N/A
- GAB N/A
- Fundamental
- Price
- HROW $38.90
- GAB $5.53
- Analyst Decision
- HROW Strong Buy
- GAB
- Analyst Count
- HROW 4
- GAB 0
- Target Price
- HROW $55.00
- GAB N/A
- AVG Volume (30 Days)
- HROW 696.6K
- GAB 667.8K
- Earning Date
- HROW 11-13-2024
- GAB 01-01-0001
- Dividend Yield
- HROW N/A
- GAB 10.91%
- EPS Growth
- HROW N/A
- GAB N/A
- EPS
- HROW N/A
- GAB N/A
- Revenue
- HROW $169,138,000.00
- GAB N/A
- Revenue This Year
- HROW $58.50
- GAB N/A
- Revenue Next Year
- HROW $48.62
- GAB N/A
- P/E Ratio
- HROW N/A
- GAB N/A
- Revenue Growth
- HROW 48.15
- GAB N/A
- 52 Week Low
- HROW $8.26
- GAB $4.56
- 52 Week High
- HROW $59.23
- GAB $5.88
- Technical
- Relative Strength Index (RSI)
- HROW 35.91
- GAB 54.45
- Support Level
- HROW $38.96
- GAB $5.33
- Resistance Level
- HROW $54.19
- GAB $5.63
- Average True Range (ATR)
- HROW 2.83
- GAB 0.06
- MACD
- HROW -0.78
- GAB 0.01
- Stochastic Oscillator
- HROW 14.77
- GAB 66.67
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.